India, Oct. 21 -- Bharat Parenterals announced that its subsidiary, Innoxel Lifesciences (Innoxel), has commenced commercial supply to the United States. The first product manufactured by Innoxel under a contract manufacturing (CMO) arrangement was launched in the U.S. market by its sponsor partner on 20 October 2026, the auspicious day of Vijayadashami.The sponsor selected Innoxel as its manufacturing partner for the product, and Auxilla Pharmaceuticals and Research LLP served as the development partner.The product is made at Innoxel's finished dosage facility in Vadodara, Gujarat, which received an Establishment Inspection Report (EIR) from the U.S. FDA in July 2025 and an EU-GMP certificate covering all four of its lines in March 2026. T...